Course Information


Infants and young children constitute a high-risk population for undergoing anesthesia and surgery due to unique anatomic, physiologic, and developmental differences compared to adults. A collaborative approach to pediatric anesthesia requires that all team members function with the most up-to-date information on caring for this challenging population. This conference will provide the anesthesia care team with current information on a variety of common pediatric anesthesia problems.

Learning Objectives for Participants

The information presented at this educational activity should improve the participants’ ability to implement evidence-based strategies for the anesthetic management of children presenting for surgical procedures and anesthesia outside of the operating room. The presentations will enable attendees to be able to:

  • Discuss diagnosis, evaluation and new therapies for treatment of malignant hyperthermia.
  • Explain current controversies surrounding acceptable minimum blood pressure in children, including neonates
  • Identify pharmacologic therapies to pediatric anesthesia that are influenced by FDA statements
  • Describe the current opioid epidemic as it relates to public policy and practice, and review implications in the pediatric patient
  • Recognize current trends in enhanced recovery pathways in pediatric anesthesia and learn ways to apply them in practice.
  • Demonstrate various methods of ultrasound technique as it relates to vascular access in the pediatric patients
  • Explain the most current roles of ECMO
  • Summarize best practices and considerations for pediatric cardiac transplant patient undergoing non-cardiac surgery

Target Audience

Anesthesiologists, CRNAs, Pediatric Intensivists, Pediatric Nurses, Residents and Fellows in Anesthesiology, Student Nurse Anesthetists, and other health care providers interested in providing care for the pediatric patient.

Accreditation Statement

The School of Medicine of the University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Statement

The School of Medicine of the University of North Carolina at Chapel Hill designates this live activity for up to 8.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This course has been prior approved by the American Association of Nurse Anesthetists for 8.0 CE credits, AANA Code Number 1035043; Expiration Date 09/23/2017. Certified nurse anesthetists should only claim credit commensurate with the extent of their participation in this activity.


This activity has been planned and implemented under the sole supervision of the course director in association with the UNC Office of Professional Development (UNC CPD). This activity has not received any commercial support as defined by the ACCME. Dr. Greene receives research support from Iroko Pharmaceuticals. None of the other planners, presenters, or UNC CPD staff have financial relationships with commercial interests.